|
EP1294358B1
(en)
|
2000-06-28 |
2004-08-18 |
Smithkline Beecham Plc |
Wet milling process
|
|
WO2002055489A2
(en)
|
2000-12-27 |
2002-07-18 |
Univ Columbia |
Pim kinase-related methods
|
|
DE10123055A1
(de)
|
2001-05-11 |
2003-03-20 |
Gruenenthal Gmbh |
Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase
|
|
DE10226702A1
(de)
|
2002-06-14 |
2004-09-09 |
Grünenthal GmbH |
Antisense Oligonukleotide gegen PIM1
|
|
WO2006078228A1
(en)
|
2002-09-16 |
2006-07-27 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
|
AU2003272548A1
(en)
|
2002-09-16 |
2004-04-30 |
Plexxikon, Inc. |
Crystal structure of pim-1 kinase
|
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
|
WO2005028624A2
(en)
|
2003-09-15 |
2005-03-31 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
|
WO2005033310A1
(de)
|
2003-10-01 |
2005-04-14 |
Grünenthal GmbH |
Pim-1-spezifische dsrna-verbindungen
|
|
WO2006006569A1
(ja)
|
2004-07-12 |
2006-01-19 |
Nihon Nohyaku Co., Ltd. |
フェニルピリジン類又はその塩類、これらを有効成分とする除草剤及びその使用方法
|
|
PL1836169T3
(pl)
|
2004-12-28 |
2012-07-31 |
Kinex Pharmaceuticals Llc |
Kompozycje i sposoby leczenia zaburzeń związanych z proliferacją komórek
|
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2007011760A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
|
CA2623759A1
(en)
|
2005-10-06 |
2007-04-19 |
Exelixis, Inc. |
Pyridopyrimidinone inhibitors of pim 1 and/or pim-3
|
|
PE20070543A1
(es)
|
2005-10-06 |
2007-06-14 |
Schering Corp |
Pirazolopirimidinas como inhibidores de protein quinasas
|
|
CA2626789A1
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrimidinones as casein kinase ii (ck2) modulators
|
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
|
WO2007084857A2
(en)
|
2006-01-13 |
2007-07-26 |
President And Fellows Of Harvard College |
Methods and compositions for treating cell proliferative disorders
|
|
WO2007131191A2
(en)
|
2006-05-05 |
2007-11-15 |
Perkinelmer Life And Analytical Sciences |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
|
JP5564251B2
(ja)
|
2006-06-29 |
2014-07-30 |
キネックス ファーマシューティカルズ， エルエルシー |
キナーゼカスケードを調節するためのビアリール組成物および方法
|
|
ES2500165T3
(es)
|
2006-06-29 |
2014-09-30 |
Kinex Pharmaceuticals, Llc |
Composiciones de biarilo y métodos para modular una cascada de quinasas
|
|
CA2660560A1
(en)
|
2006-08-16 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Pyrazine compounds, their use and methods of preparation
|
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
|
KR20090082440A
(ko)
|
2006-10-31 |
2009-07-30 |
쉐링 코포레이션 |
단백질 키나제 억제제로서의 2-아미노티아졸-4-카복실산 아미드
|
|
US7750007B2
(en)
|
2006-11-06 |
2010-07-06 |
Supergen, Inc. |
Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
WO2008082839A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
|
WO2008082840A1
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
|
CN101679266B
(zh)
|
2007-03-01 |
2015-05-06 |
诺华股份有限公司 |
Pim激酶抑制剂及其应用方法
|
|
JP2010522765A
(ja)
|
2007-03-28 |
2010-07-08 |
アレイ バイオファーマ、インコーポレイテッド |
受容体チロシンキナーゼとしてのイミダゾ［１，２−ａ］ピリジン化合物
|
|
UA101611C2
(ru)
|
2007-04-03 |
2013-04-25 |
Аррей Байофарма Инк. |
СОЕДИНЕНИЯ ИМИДАЗО[1,2-а]ПИРИДИНА КАК ИНГИБИТОРЫ ТИРОЗИНКИНАЗЫ РЕЦЕПТОРОВ
|
|
US8242129B2
(en)
|
2007-04-25 |
2012-08-14 |
Exelixis, Inc. |
6-phenylpyrimidinones as PIM modulators
|
|
EP2074114B1
(en)
|
2007-04-25 |
2013-03-06 |
Exelixis, Inc. |
Pyrimidinones as casein kinase ii (ck2) modulators
|
|
BRPI0814441A2
(pt)
*
|
2007-07-19 |
2015-07-14 |
Schering Corp |
Compostos de amida heterocíclica como inibidores de proteína cinase
|
|
KR20100042287A
(ko)
|
2007-07-31 |
2010-04-23 |
쉐링 코포레이션 |
항암요법으로서의 항-유사분열제 및 아우로라 키나제 억제제 조합물
|
|
CA2743756A1
(en)
|
2007-11-15 |
2009-05-22 |
Musc Foundation For Research Development |
Inhibitors of pim protein kinases, compositions, and methods for treating cancer
|
|
CA2705862C
(en)
|
2007-11-16 |
2018-03-27 |
San Diego State University Research Foundation |
Compositions and method for manipulating pim-1 activity in circulatory system cells
|
|
CN102036561A
(zh)
|
2008-02-29 |
2011-04-27 |
赛林药物股份有限公司 |
蛋白激酶调节剂
|
|
PE20091577A1
(es)
|
2008-03-03 |
2009-11-05 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso
|
|
US8168794B2
(en)
*
|
2008-03-03 |
2012-05-01 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
|
US20110237600A1
(en)
|
2008-05-12 |
2011-09-29 |
Amnestix, Inc. |
Compounds for improving learning and memory
|
|
CN102137866A
(zh)
|
2008-06-30 |
2011-07-27 |
赛林药物股份有限公司 |
羟吲哚化合物
|
|
UY31952A
(es)
|
2008-07-02 |
2010-01-29 |
Astrazeneca Ab |
5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
|
|
FR2933409B1
(fr)
|
2008-07-03 |
2010-08-27 |
Centre Nat Rech Scient |
NOUVEAUX PYRROLO °2,3-a! CARBAZOLES ET LEUR UTILISATION COMME INHIBITEURS DES KINASES PIM
|
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
|
|
WO2010026122A1
(en)
|
2008-09-02 |
2010-03-11 |
Novartis Ag |
Heterocyclic pim-kinase inhibitors
|
|
PT2344474E
(pt)
|
2008-09-02 |
2015-12-28 |
Novartis Ag |
Derivados de picolinamida como inibidores de cinase
|
|
JP5564045B2
(ja)
|
2008-09-02 |
2014-07-30 |
ノバルティス アーゲー |
二環式キナーゼ阻害剤
|
|
CN102264736B
(zh)
|
2008-10-22 |
2013-08-14 |
阵列生物制药公司 |
作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
|
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
WO2010071885A1
(en)
|
2008-12-19 |
2010-06-24 |
Cephalon, Inc. |
Pyrrolotriazines as alk and jak2 inhibitors
|
|
US20120128631A1
(en)
|
2009-05-19 |
2012-05-24 |
San Diego State University (SDSU) Foundation, dba San Diego State University (SDSU) Research |
Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
|
|
US20100298302A1
(en)
|
2009-05-20 |
2010-11-25 |
Fabrice Pierre |
Novel protein kinase modulators
|
|
NZ596571A
(en)
|
2009-05-20 |
2013-03-28 |
Cylene Pharmaceuticals Inc |
Pyrazolopyrimidines and related heterocycles as kinase inhibitors
|
|
NZ596479A
(en)
|
2009-05-22 |
2014-01-31 |
Incyte Corp |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
WO2010148351A1
(en)
|
2009-06-18 |
2010-12-23 |
Cylene Pharmaceuticals, Inc. |
Rhodanines and related heterocycles as kinase inhibitors
|
|
EP2448938B9
(en)
|
2009-06-29 |
2015-06-10 |
Incyte Corporation |
Pyrimidinones as pi3k inhibitors
|
|
WO2011025859A1
(en)
|
2009-08-26 |
2011-03-03 |
Cylene Pharmaceuticals, Inc. |
Condensed quinolines as protein kinase modulators
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
WO2011029802A1
(en)
|
2009-09-08 |
2011-03-17 |
F. Hoffmann-La Roche Ag |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
|
MX2012002994A
(es)
|
2009-09-11 |
2012-07-17 |
Cylene Pharmaceuticals Inc |
Lactamas heterociclo-substituidas farmaceuticamente utiles.
|
|
CN102647904A
(zh)
|
2009-09-16 |
2012-08-22 |
赛林药物股份有限公司 |
新型三环蛋白激酶调节剂
|
|
AU2010295622A1
(en)
|
2009-09-16 |
2012-05-10 |
Cylene Pharmaceuticals, Inc. |
Tricyclic compounds and pharmaceutical uses thereof
|
|
JP5993742B2
(ja)
|
2009-10-29 |
2016-09-14 |
ジェノスコ |
キナーゼ阻害剤
|
|
EP2332917B1
(en)
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
|
WO2011058139A1
(en)
|
2009-11-12 |
2011-05-19 |
Selvita Sp. Z O. O. |
A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
|
|
US8304172B2
(en)
|
2009-11-12 |
2012-11-06 |
Advanced Micro Devices, Inc. |
Semiconductor device fabrication using a multiple exposure and block mask approach to reduce design rule violations
|
|
CA2780892C
(en)
|
2009-11-13 |
2017-02-14 |
Genosco |
Kinase inhibitors
|
|
US8853235B2
(en)
|
2009-11-23 |
2014-10-07 |
Senhwa Biosciences, Inc. |
Polymorphs and salts of a kinase inhibitor
|
|
PL2509602T3
(pl)
|
2009-12-04 |
2017-08-31 |
Senhwa Biosciences, Inc. |
Pirazolopirymidyny i podobne heterocykle jako inhibitory ck2
|
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
|
WO2011075630A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
|
|
WO2011075613A1
(en)
|
2009-12-18 |
2011-06-23 |
Sanofi |
Azaindole derivatives, their preparation and their therapeutic application
|
|
WO2011079274A1
(en)
|
2009-12-23 |
2011-06-30 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
|
GB201002861D0
(en)
|
2010-02-19 |
2010-04-07 |
Cxr Biosciences Ltd |
Compositions
|
|
CA2792508C
(en)
|
2010-03-10 |
2018-01-16 |
Incyte Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
CA2794801C
(en)
|
2010-04-07 |
2019-01-15 |
F. Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
|
WO2012004217A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
|
JP5985473B2
(ja)
|
2010-07-13 |
2016-09-06 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ＩＲＡＫ４モジュレーターとしてのピラゾロ［１，５ａ］ピリミジン及びチエノ［３，２ｂ］ピリミジン誘導体
|
|
HUE052110T2
(hu)
|
2010-07-29 |
2021-04-28 |
Rigel Pharmaceuticals Inc |
AMPK-t aktiváló heterociklusos vegyületek és alkalmazásuk
|
|
US8227773B2
(en)
|
2010-07-29 |
2012-07-24 |
Axcelis Technologies, Inc. |
Versatile beam glitch detection system
|
|
EP2662078A1
(en)
|
2010-11-10 |
2013-11-13 |
National Jewish Health |
Methods to Treat Allergic Conditions
|
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
ES2536415T3
(es)
|
2010-11-19 |
2015-05-25 |
Incyte Corporation |
Pirrolopiridinas y pirrolopirimidinas sustituidas heterocíclicas como inhibidores de JAK
|
|
JP2014500277A
(ja)
|
2010-12-09 |
2014-01-09 |
アムジエン・インコーポレーテツド |
Ｐｉｍ阻害剤としての二環式化合物
|
|
BR112013008527A2
(pt)
|
2010-12-17 |
2016-07-12 |
Nerviano Medical Sciences Srl |
derivados de pirazolo-quinazolina substituídos como inibidores de cinase
|
|
JP5961187B2
(ja)
|
2010-12-20 |
2016-08-02 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｐｉ３ｋ阻害剤としてのｎ−（１−（置換フェニル）エチル）−９ｈ−プリン−６−アミン
|
|
EP2668188B1
(en)
|
2011-01-26 |
2016-05-18 |
Nerviano Medical Sciences S.r.l. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
|
US8975267B2
(en)
|
2011-01-26 |
2015-03-10 |
Nerviano Medical Sciences S.R.L. |
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
|
|
MX339899B
(es)
|
2011-02-25 |
2016-06-16 |
Array Biopharma Inc |
Compuestos de triazolopiridina como inhibidores de pim cinasa.
|
|
JP2014506915A
(ja)
|
2011-03-04 |
2014-03-20 |
ノバルティス アーゲー |
キナーゼ阻害剤としての四置換シクロヘキシル化合物
|
|
UY33930A
(es)
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
WO2012129338A1
(en)
|
2011-03-22 |
2012-09-27 |
Amgen Inc. |
Azole compounds as pim inhibitors
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
EP2694509B1
(en)
|
2011-04-05 |
2016-05-18 |
Pfizer Limited |
Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of tropomyosin-related kinases
|
|
US9284298B2
(en)
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
|
WO2012145617A2
(en)
|
2011-04-22 |
2012-10-26 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
|
GB201107176D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Pyrrolnitrin derivatives
|
|
GB201107197D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Compounds
|
|
JP2014516941A
(ja)
|
2011-04-29 |
2014-07-17 |
アムジェン インコーポレイテッド |
Ｐｉｍ阻害剤としての二環式ピリダジン化合物
|
|
CA2836203A1
(en)
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
|
AU2012257513B2
(en)
|
2011-05-19 |
2017-05-11 |
Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Macrocyclic compounds as protein kinase inhibitors
|
|
KR20140048891A
(ko)
|
2011-05-27 |
2014-04-24 |
템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
치환된 2-벤질리덴-2H-벤조[b][1,4]티아진-3(4H)-온, 이의 유도체, 및 이의 치료적 용도
|
|
CA2837630A1
(en)
|
2011-06-01 |
2012-12-06 |
Knut Eis |
Substituted aminoimidazopyridazines
|
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
|
US8691807B2
(en)
|
2011-06-20 |
2014-04-08 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
|
|
EP2723748B1
(en)
|
2011-06-22 |
2016-10-12 |
Bayer Intellectual Property GmbH |
Heterocyclyl aminoimidazopyridazines
|
|
DK2734205T3
(en)
|
2011-07-21 |
2018-06-14 |
Tolero Pharmaceuticals Inc |
Heterocyclic Protein Kinase Inhibitors
|
|
CN102924445B
(zh)
|
2011-08-11 |
2015-07-08 |
上海吉铠医药科技有限公司 |
Pim激酶抑制剂及其制备方法与在制药中的应用
|
|
US9260425B2
(en)
|
2011-08-12 |
2016-02-16 |
Genetech, Inc. |
Pyrazolo[3,4-c]pyridine compounds and methods of use
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
JP5843524B2
(ja)
|
2011-09-02 |
2016-01-13 |
キヤノン株式会社 |
有機無機複合組成物、有機無機複合材料、光学素子および積層型回折光学素子
|
|
MX389479B
(es)
|
2011-09-02 |
2025-03-20 |
Incyte Holdings Corp |
Heterociclilaminas como inhibidores de fosfoinositida 3-cinasas (pi3k)
|
|
UA117092C2
(uk)
|
2011-09-06 |
2018-06-25 |
Байєр Інтеллектуал Проперті Гмбх |
Амінозаміщені імідазопіридазини
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
US9320737B2
(en)
|
2011-09-23 |
2016-04-26 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
|
EP2760857A1
(en)
|
2011-09-27 |
2014-08-06 |
F.Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
|
ES2660265T3
(es)
|
2011-10-07 |
2018-03-21 |
Nerviano Medical Sciences S.R.L. |
Derivados de 3,4-dihidropirrolo[1,2-a]pirazin-1(2h)-ona 4-alquil-sustituidos como inhibidores de cinasa
|
|
WO2013050446A1
(en)
|
2011-10-07 |
2013-04-11 |
Nerviano Medical Sciences S.R.L. |
SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
|
BR112014010563B1
(pt)
|
2011-11-04 |
2021-01-12 |
Jasco Pharmaceuticals, LLC |
compostos inibidores da aminopirimidina quinase
|
|
WO2013130660A1
(en)
|
2012-02-28 |
2013-09-06 |
Amgen Inc. |
Amides as pim inhibitors
|
|
EP2822944A1
(en)
|
2012-03-05 |
2015-01-14 |
Amgen, Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
WO2013144189A1
(en)
|
2012-03-29 |
2013-10-03 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
EP2834245B1
(en)
|
2012-04-04 |
2017-12-13 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazopyridazines
|
|
ES2640916T3
(es)
|
2012-04-26 |
2017-11-07 |
Bristol-Myers Squibb Company |
Derivados de imidazotiadiazol e imidazopirazina como inhibidores del receptor 4 activados por proteasa (PAR4) para tratar agregación plaquetaria
|
|
MA37439B1
(fr)
|
2012-04-27 |
2017-02-28 |
Novartis Ag |
Inhibiteurs de dgat1 à ponts éthers cycliques pour le traitement de troubles medies par l'acyle coa-diacylglycerol transferase 1 (dgat1).
|
|
SMT202000347T1
(it)
|
2012-05-09 |
2020-07-08 |
Biogen Ma Inc |
Modulatori di trasporto nucleare e loro usi
|
|
ES2670601T3
(es)
|
2012-05-15 |
2018-05-31 |
Novartis Ag |
Derivados de benzamida para la inhibición de la actividad de ABL1, ABL2 y BCR-ABL1
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
CN104334546B
(zh)
|
2012-05-21 |
2017-05-03 |
诺华股份有限公司 |
作为激酶抑制剂的新的环‑取代的n‑吡啶基酰胺
|
|
MD20140134A2
(ro)
|
2012-05-22 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
|
|
TWI568722B
(zh)
|
2012-06-15 |
2017-02-01 |
葛蘭馬克製藥公司 |
作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物
|
|
KR20150028999A
(ko)
|
2012-06-27 |
2015-03-17 |
에프. 호프만-라 로슈 아게 |
5-아자인다졸 화합물 및 이의 사용 방법
|
|
AR092348A1
(es)
|
2012-07-11 |
2015-04-15 |
Hoffmann La Roche |
DERIVADOS DE ARIL-SULTAMO COMO MODULADORES DE RORc
|
|
TW201414737A
(zh)
|
2012-07-13 |
2014-04-16 |
必治妥美雅史谷比公司 |
作爲激酶抑制劑之咪唑并三□甲腈
|
|
WO2014022752A1
(en)
|
2012-08-03 |
2014-02-06 |
Amgen Inc. |
Macrocycles as pim inhibitors
|
|
WO2014033630A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Novel aminothiazole carboxamides as kinase inhibitors
|
|
WO2014033631A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
N-(3-pyridyl) biarylamides as kinase inhibitors
|
|
CN103664878A
(zh)
|
2012-09-12 |
2014-03-26 |
山东亨利医药科技有限责任公司 |
杂芳环及其衍生物类酪氨酸激酶抑制剂
|
|
BR112015005743A2
(pt)
|
2012-09-14 |
2017-07-04 |
Abbvie Deutschland |
derivados tricíclicos de quinoxalina e quinolina
|
|
WO2014048939A1
(en)
|
2012-09-26 |
2014-04-03 |
F. Hoffmann-La Roche Ag |
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
|
WO2014053568A1
(en)
|
2012-10-02 |
2014-04-10 |
Sanofi |
Indolyldihydroimidazopyrimidinone derivatives, preparation thereof and therapeutic use thereof
|
|
AU2013334001B2
(en)
|
2012-10-16 |
2017-07-20 |
Janssen Sciences Ireland Uc |
RSV antiviral compounds
|
|
CA2888816A1
(en)
|
2012-11-01 |
2014-05-08 |
Incyte Corporation |
Tricyclic fused thiophene derivatives as jak inhibitors
|
|
ES2646916T3
(es)
|
2012-11-19 |
2017-12-18 |
Bayer Pharma Aktiengesellschaft |
Aminoimidazopiridazinas como inhibidores de MKNK1 cinasa
|
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
|
LT3418281T
(lt)
|
2012-12-07 |
2021-01-11 |
Vertex Pharmaceuticals Inc. |
Pirazolo[1,5-a]pirimidinai, naudotini kaip atr kinazės inhibitoriai, skirti vėžinių ligų gydymui
|
|
WO2014088117A1
(ja)
|
2012-12-07 |
2014-06-12 |
トヨタ自動車株式会社 |
車体端部構造
|
|
NZ708928A
(en)
|
2012-12-18 |
2020-04-24 |
Vertex Pharma |
Mannose derivatives for treating bacterial infections
|
|
US20150336960A1
(en)
|
2012-12-19 |
2015-11-26 |
Novartis Ag |
Aryl-substituted fused bicyclic pyridazine compounds
|
|
EP2935249B1
(en)
|
2012-12-19 |
2018-12-12 |
Novartis AG |
Autotaxin inhibitors
|
|
US9604930B2
(en)
|
2012-12-21 |
2017-03-28 |
Epizyme, Inc. |
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
|
|
EA030003B1
(ru)
|
2012-12-21 |
2018-06-29 |
Джилид Сайэнс, Инк. |
Полициклическое карбамоилпиридоновое соединение и его фармацевтическое применение для лечения вич-инфекции
|
|
FR3000569B1
(fr)
|
2013-01-03 |
2015-02-13 |
Peugeot Citroen Automobiles Sa |
Dispositif d'eclairage a ecran a bord(s) lumineux
|
|
EP2943485B1
(en)
|
2013-01-14 |
2017-09-20 |
Incyte Holdings Corporation |
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
|
|
TWI662030B
(zh)
|
2013-01-15 |
2019-06-11 |
英塞特控股公司 |
適用作ｐｉｍ激酶抑制劑之噻唑甲醯胺及吡啶甲醯胺化合物
|
|
TWI736135B
(zh)
|
2013-03-01 |
2021-08-11 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
|
EP3489239B1
(en)
|
2013-03-06 |
2021-09-15 |
Incyte Holdings Corporation |
Processes and intermediates for making a jak inhibitor
|
|
JO3383B1
(ar)
|
2013-03-14 |
2019-03-13 |
Lilly Co Eli |
مثبطات cdc7
|
|
TWI689490B
(zh)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
用於治療纖維化之經取代之芳族化合物及相關方法
|
|
TWI742541B
(zh)
|
2013-03-15 |
2021-10-11 |
英商邊緣生物科技有限公司 |
用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
|
|
TW201522341A
(zh)
|
2013-03-15 |
2015-06-16 |
Respivert Ltd |
化合物
|
|
HRP20171763T1
(hr)
|
2013-03-15 |
2017-12-29 |
Idorsia Pharmaceuticals Ltd |
Derivati piridin-4-ila
|
|
US20160052926A1
(en)
|
2013-03-15 |
2016-02-25 |
Hutchison Medipharma Limited |
Novel pyrimidine and pyridine compounds and usage thereof
|
|
EP2968299B1
(en)
|
2013-03-15 |
2021-01-20 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
CN105073747B
(zh)
|
2013-03-15 |
2017-06-06 |
普莱希科公司 |
杂环化合物及其应用
|
|
TWI633885B
(zh)
|
2013-03-15 |
2018-09-01 |
日商日本煙草產業股份有限公司 |
吡唑－醯胺化合物及其醫藥用途
|
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
|
BR112015021982B1
(pt)
|
2013-03-15 |
2022-12-13 |
Global Blood Therapeutics, Inc |
Compostos e seus usos para a modulação de hemoglobina
|
|
EA035469B1
(ru)
|
2013-03-15 |
2020-06-22 |
Инсайт Холдингс Корпорейшн |
Трициклические гетероциклы как ингибиторы белков бэт
|
|
UY35421A
(es)
|
2013-03-15 |
2014-10-31 |
Nihon Nohyaku Co Ltd |
Compuesto heterocíclico condensado o su sal, insecticida agrícola u hortícola que comprende el comp uesto y método de uso del insecticida
|
|
KR20210125575A
(ko)
|
2013-03-15 |
2021-10-18 |
코르테바 애그리사이언스 엘엘씨 |
4-아미노-6-(헤테로시클릭)피콜리네이트 및 6-아미노-2-(헤테로시클릭)피리미딘-4-카르복실레이트 및 제초제로서의 그의 용도
|
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
|
US20140275108A1
(en)
|
2013-03-15 |
2014-09-18 |
Galderma Research & Development |
Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
|
|
MX376856B
(es)
|
2013-08-07 |
2025-03-07 |
Incyte Holdings Corp |
Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
|
|
US9556197B2
(en)
|
2013-08-23 |
2017-01-31 |
Incyte Corporation |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
|
|
SG11201607083VA
(en)
|
2014-02-28 |
2016-09-29 |
Incyte Corp |
Jak1 inhibitors for the treatment of myelodysplastic syndromes
|
|
CA3158254C
(en)
|
2014-04-08 |
2024-05-21 |
Incyte Corporation |
Treatment of b-cell malignancies by a combination jak and pi3k inhibitors
|
|
SG11201609016VA
(en)
|
2014-04-30 |
2016-11-29 |
Incyte Corp |
Processes of preparing a jak1 inhibitor and new forms thereto
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
WO2016010897A1
(en)
|
2014-07-14 |
2016-01-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
|
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|